论文信息 - Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA) - 字舞流文

Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA)

D. M. van der Heijde | D. Heijde | A. Deodhar | P. Mease | M. Khraishi | R. Fleischmann | D. Kielar | F. Woltering | J. Wollenhaupt | C. Stach | B. Hoepken | T. Arledge | D. V. D. Heijde